Capricor Therapeutics (4LN2) Cash flow

0 Followers

Capricor Therapeutics Cash Flow

DE:4LN2's free cash flow for Q2 2026 was $-37.39M. For the 2026 fiscal year, DE:4LN2's free cash flow was decreased by $-31.18M and operating cash flow was $-31.49M. See a summary of the company’s cash flow.

Cash Flow	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Operating Cash Flow	$ -69.81M	$ -40.00M	$ -25.60M	$ 4.92M	$ -16.81M
Investing Cash Flow	$ 97.48M	$ -116.18M	$ 5.11M	$ -35.07M	$ -1.20M
Financing Cash Flow	$ 248.89M	$ 152.77M	$ 25.58M	$ 4.87M	$ 20.23M
End Cash Position	$ 287.85M	$ 11.29M	$ 14.69M	$ 9.60M	$ 34.89M
Free Cash Flow	$ -72.72M	$ -41.53M	$ -27.64M	$ 1.56M	$ -18.01M

Currency in USD